Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- January 2020
- DOI:
- 10.1371/journal.pone.0225301
- Bibcode:
- 2020PLoSO..1525301B